NM_014817.4:c.2402G>A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014817.4(TRIL):c.2402G>A(p.Arg801Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000518 in 1,545,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014817.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIL | ENST00000539664.3 | c.2402G>A | p.Arg801Gln | missense_variant | Exon 1 of 1 | 6 | NM_014817.4 | ENSP00000479256.1 | ||
CPVL-AS2 | ENST00000749297.1 | n.-111C>T | upstream_gene_variant | |||||||
CPVL-AS2 | ENST00000749329.1 | n.-249C>T | upstream_gene_variant | |||||||
CPVL-AS2 | ENST00000749333.1 | n.-233C>T | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000272 AC: 4AN: 146942 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000502 AC: 7AN: 1393572Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 687362 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2402G>A (p.R801Q) alteration is located in exon 1 (coding exon 1) of the TRIL gene. This alteration results from a G to A substitution at nucleotide position 2402, causing the arginine (R) at amino acid position 801 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at